S-100B and Neuron-specific Enolase (NSE) in Spinal Trauma

The investigators are studying the clinical worth of the serum markers S-100B and NSE in patients with spinal cord injuries e.g. in patients with vertebral fractures. If there is a injury to the neuronal structures these two proteins could be secreted into the serum and add evidence to the severity of the injury.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Spinal Cord Injury Back Injuries Central Nervous System Diseases Fractures, Bone Nervous System Diseases Spinal Cord Diseases Spinal Cord Injuries Spinal Fractures Spinal Injuries Trauma, Nervous System Wounds and Injuries

Age range

1 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Medical University of Vienna

Vienna, State of Vienna, 1090, Austria

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

vertebral fracture
injuries to the vertebral spine

Exclusion criteria

head trauma
polytrauma

Treatment and study plan

Primary outcomes

Neurological Symptoms

Time frame: 2 weeks

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

Medical University of Vienna

Other

Registry information

Official study title

The Clinical Use of S-100B and NSE in Spinal Cord Injuries

Acronym: WBS

Important dates

Study start: 2008
Primary completion: 2011
Study completion: 2011
First posted: Sep 21, 2009
Registry last updated: Apr 4, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed